Hepatitis C recurrence in liver transplant recipients.
Kizilisik
T A
TA
King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
al-Sebayel
M
M
Hammad
A
A
al-Traif
I
I
Ramirez
C G
CG
Abdulla
A
A
D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006085:Graft Survival; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000473:pathology / Q000601:surgery* / Q000628:therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000401:mortality / Q000473:pathology; D012367:RNA, Viral / Q000302:isolation & purification; D012008:Recurrence; D012254:Ribavirin / Q000627:therapeutic use*; D015996:Survival Rate; D013997:Time Factors
D000998:Antiviral Agents; D012367:RNA, Viral; D012254:Ribavirin; D007372:Interferons; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin